Metastatic Breast Cancer Guidelines for Patients from National Comprehensive Cancer Network (NCCN)
Looking for an overview of MBC and its treatments? See https://www.nccn.org/patients/guidelines/stage_iv_breast/index.html
Oligometastatic Breast Cancer Patients Salute Dr. Weichselbaum and Work to Educate Others
“Oligometastatic” is hard to say but few words convey more hope to certain cancer patients, thanks to the pioneering efforts of the Dr.... Read More
Know What Your Doctors Know: Mestastatic Breast Cancer Webinar October 2018
NCCN is hosting a free live webinar focusing on metastatic breast cancer especially for patients and their family members. The webinar... Read More
Metastatic Breast Cancer: Your Calendar of Fall 2018 Events
Here’s a round up of the metastatic breast cancer events coming up in the next few weeks and months. Did we miss... Read More
Metastatic Breast Cancer: Overcoming Isolation and Exposing Misconceptions
Editor’s Note: MBCN’s Lila Romeo gave the following speech at a press briefing for the Global Advocacy Working Group on September 19, 2008. Sponsored... Read More
NYC: Metastatic Breast Cancer Conference: Oct 27
In association with the Metastatic Breast Cancer Network (MBCN), SHARE and Sharsheret, Susan G. Komen Greater NYC invites you to join us... Read More
Seattle Northwest Metastatic Breast Cancer Conference: Sept 22-23 2017
The Northwest Metastatic Breast Cancer Conference is supported by Susan G. Komen Puget Sound in partnership with Amazon Web Services, Swedish... Read More
Finding Metastatic Breast Cancer Clinical Trials: the Metastatic Trial Search Engine
Are you looking for a metastatic breast cancer clinical trial? A new search engine, a project made possible by the Metastatic Breast... Read More
Clinical Trials for Metastatic Breast Cancer Webinar: April 21, Noon CST
MBCN Teams With Research Advocacy Network to Offer Webinar on Clinical Trials for Metastatic Breast Cancer DATE: Friday April 21, 2017 TIME:... Read More
Dramatic Advances in HER2+ Breast Cancer over the Past 10 Years
In an interview with OncLive, Dr. Sara Hurvitz, from UCLA, discusses ongoing advances that continue to revolutionize the treatment of patients with HER2+... Read More